OSAKA -- Ono Pharmaceutical will develop a diagnostic test to identify patients who would benefit from its Opdivo cancer drug, allowing for more efficient treatment and lower medical costs.
Articles
OSAKA -- Ono Pharmaceutical will develop a diagnostic test to identify patients who would benefit from its Opdivo cancer drug, allowing for more efficient treatment and lower medical costs.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.